Lefamulin NDA Filed in Mainland China for Treatment of Community Acquired Pneumonia

This filing brings Nabriva and Sumitomo Pharmaceuticals (Suzhou) Co., Ltd. one step closer to their goal of offering lefamulin to patients with CAP in China.